| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloid leukemia with minimal differentiation: Unusual cytogenetics, morphology, phenotype and clinical course
|
Rohon, Peter
|
|
2012
|
36 |
7 |
p. e133-e136
nvt p.
|
artikel
|
| 2 |
Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
|
Barbany, Gisela
|
|
2012
|
36 |
7 |
p. 936-938
3 p.
|
artikel
|
| 3 |
Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia
|
Gater, Adam
|
|
2012
|
36 |
7 |
p. 817-825
9 p.
|
artikel
|
| 4 |
Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
|
Breccia, Massimo
|
|
2012
|
36 |
7 |
p. 804-805
2 p.
|
artikel
|
| 5 |
ALK-positive anaplastic large cell lymphoma with TPM3-ALK translocation
|
Shin, Saeam
|
|
2012
|
36 |
7 |
p. e143-e145
nvt p.
|
artikel
|
| 6 |
A new recurrent chromosomal translocation t(3;11)(q13;q14) in myelodysplastic syndromes associated with overexpression of the ILDR1 gene
|
Zagaria, Antonella
|
|
2012
|
36 |
7 |
p. 852-856
5 p.
|
artikel
|
| 7 |
A role for caspase inhibitors in differentiation therapy of myeloid leukaemia
|
Brown, Geoffrey
|
|
2012
|
36 |
7 |
p. 808-810
3 p.
|
artikel
|
| 8 |
Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML
|
Rosen, David B.
|
|
2012
|
36 |
7 |
p. 900-904
5 p.
|
artikel
|
| 9 |
Azacitidine differentially affects CD4pos T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes
|
Bontkes, Hetty J.
|
|
2012
|
36 |
7 |
p. 921-930
10 p.
|
artikel
|
| 10 |
CD105 and placental growth factor – Potent prognostic factors in childhood acute lymphoblastic leukaemia
|
Sujka-Kordowska, Patrycja
|
|
2012
|
36 |
7 |
p. 846-851
6 p.
|
artikel
|
| 11 |
Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks
|
Huang, Hongming
|
|
2012
|
36 |
7 |
p. 841-845
5 p.
|
artikel
|
| 12 |
Cytogenetics in myelodysplastic syndromes: Old methods, new clues
|
Rigolin, Gian Matteo
|
|
2012
|
36 |
7 |
p. 806-807
2 p.
|
artikel
|
| 13 |
Downregulation of IRS2 in myelodysplastic syndrome: A possible role in impaired hematopoietic cell differentiation
|
Machado-Neto, João Agostinho
|
|
2012
|
36 |
7 |
p. 931-935
5 p.
|
artikel
|
| 14 |
Editorial Board
|
|
|
2012
|
36 |
7 |
p. CO2-
1 p.
|
artikel
|
| 15 |
Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: Effect of 5-AZA treatment
|
Gutierrez-Cosío, S.
|
|
2012
|
36 |
7 |
p. 895-899
5 p.
|
artikel
|
| 16 |
Establishment and characterization of a new human acute myelomonocytic leukemia cell line JIH-3
|
Pan, Jinlan
|
|
2012
|
36 |
7 |
p. 889-894
6 p.
|
artikel
|
| 17 |
Expression of soluble HLA-G in multiple myeloma patients and patients with renal failure
|
Wlasiuk, Paulina
|
|
2012
|
36 |
7 |
p. 881-883
3 p.
|
artikel
|
| 18 |
Extranodal marginal zone lymphoma of the CNS arising after a long-standing history of atypical white matter disease
|
Schiefer, Ana-Iris
|
|
2012
|
36 |
7 |
p. e155-e157
nvt p.
|
artikel
|
| 19 |
High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients
|
Butrym, Aleksandra
|
|
2012
|
36 |
7 |
p. 876-880
5 p.
|
artikel
|
| 20 |
Hypersensitivity to alkylation treatment of primary fibroblasts from patients with therapy-related myeloid neoplasms
|
Rankl, Julia
|
|
2012
|
36 |
7 |
p. e137-e139
nvt p.
|
artikel
|
| 21 |
Long term follow-up of Polycythemia Vera patients treated with imatinib mesylate
|
Michael Jones, C.
|
|
2012
|
36 |
7 |
p. 815-816
2 p.
|
artikel
|
| 22 |
Mycosis fungoides with testicular involvement: A rare phenomenon
|
Khawaja, Muhammad Rizwan
|
|
2012
|
36 |
7 |
p. e149-e152
nvt p.
|
artikel
|
| 23 |
Neutrophilic panniculitis following azacitidine treatment for myelodysplastic syndromes
|
Kim, In-Ho
|
|
2012
|
36 |
7 |
p. e146-e148
nvt p.
|
artikel
|
| 24 |
New complex chromosome abnormalities in multiple myeloma associated with a poor prognosis: A case report
|
Fett-Conte, Agnes C.
|
|
2012
|
36 |
7 |
p. e140-e142
nvt p.
|
artikel
|
| 25 |
Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL
|
Gusscott, Samuel
|
|
2012
|
36 |
7 |
p. 905-911
7 p.
|
artikel
|
| 26 |
Obesity but not overweight increases the incidence and mortality of leukemia in adults: A meta-analysis of prospective cohort studies
|
Castillo, Jorge J.
|
|
2012
|
36 |
7 |
p. 868-875
8 p.
|
artikel
|
| 27 |
Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL)
|
Ceesay, M. Mansour
|
|
2012
|
36 |
7 |
p. 857-861
5 p.
|
artikel
|
| 28 |
Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course
|
Bacher, Ulrike
|
|
2012
|
36 |
7 |
p. 826-831
6 p.
|
artikel
|
| 29 |
Progressive arterial occlusive disease (PAOD) and pulmonary arterial hypertension (PAH) as new adverse events of second generation TKIs in CML treatment: Who's afraid of the big bad wolf?
|
Breccia, Massimo
|
|
2012
|
36 |
7 |
p. 813-814
2 p.
|
artikel
|
| 30 |
Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia
|
Vázquez-Franco, José E.
|
|
2012
|
36 |
7 |
p. 862-867
6 p.
|
artikel
|
| 31 |
Stevens-Johnson syndrome after treatment with bendamustine
|
Lambertini, Matteo
|
|
2012
|
36 |
7 |
p. e153-e154
nvt p.
|
artikel
|
| 32 |
The dual PI3K and mTOR inhibitor NVP-BEZ235 exhibits anti-proliferative activity and overcomes bortezomib resistance in mantle cell lymphoma cells
|
Kim, Areumnuri
|
|
2012
|
36 |
7 |
p. 912-920
9 p.
|
artikel
|
| 33 |
The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells
|
Chen-Deutsch, Xiangwen
|
|
2012
|
36 |
7 |
p. 884-888
5 p.
|
artikel
|
| 34 |
The place of sideroblastic erythropoiesis in WHO 2008 classification of MDS; RCMD versus RCMD-RD as combined or a separate entity?
|
Yoshida, Yataro
|
|
2012
|
36 |
7 |
p. 811-812
2 p.
|
artikel
|
| 35 |
Towards a need to a “biological Sokal risk” in the era of tyrosine kinase inhibitors in choosing front-line therapy in chronic myeloid leukemia
|
Stagno, Fabio
|
|
2012
|
36 |
7 |
p. 803-
1 p.
|
artikel
|
| 36 |
Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?
|
Cherry, Athena M.
|
|
2012
|
36 |
7 |
p. 832-840
9 p.
|
artikel
|
Tijdschrift beschrijving